GlaxoSmithKline, the pharmaceutical giant, has announced plans to move 1,000 scientists from Stevenage to a new 30,000 sq.m R&D centre in the Cambridge Biomedical Campus. Prologis is the development partner for the new centre, which is planned across three interconnected buildings and is part of GSK’s plan to accelerate its research and development pipeline.
